Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study

Overview

Journal Alzheimer Dis Assoc Disord

Specialties Neurology
Psychiatry

Date 2015 Oct 21

PMID 26485498

Citations 95

Authors

Sarah E Monsell

Hiroko H Dodge

Xiao-Hua Zhou

Yunqi Bu

Lilah M Besser

Charles Mock

Stephen E Hawes

Walter A Kukull

Sandra Weintraub

Affiliations

Soon will be listed here.

Abstract

Introduction: Four new nonproprietary tests were recommended for use in the National Alzheimer's Coordinating Center's Uniform Data Set Neuropsychological Battery. These tests are similar to previous tests but also allow for continuity of longitudinal data collection and wide dissemination among research collaborators.

Methods: A Crosswalk Study was conducted in early 2014 to assess the correlation between each set of new and previous tests. Tests with good correlation were equated using equipercentile equating. The resulting conversion tables allow scores on the new tests to be converted to equivalent scores on the previous tests.

Results: All pairs of tests had good correlation (ρ=0.68 to 0.78). Learning effects were detected for Logical Memory only. Confidence intervals were narrow at each point estimate, and prediction accuracy was high.

Discussion: The recommended new tests are well correlated with the previous tests. The equipercentile equating method produced conversion tables that provide a useful reference for clinicians and researchers.

Citing Articles

Association of Alzheimer's and Lewy body disease pathology with basal forebrain volume and cognitive impairment.

Schumacher J, Teipel S, Storch A Alzheimers Res Ther. 2025; 17(1):28.

PMID: 39865328 PMC: 11771035. DOI: 10.1186/s13195-025-01678-x.

Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.

Hammers D, Eloyan A, Thangarajah M, Taurone A, Beckett L, Gao S Alzheimers Dement. 2024; 21(1):e14218.

PMID: 39711228 PMC: 11772709. DOI: 10.1002/alz.14218.

Targeted Proteomic Biomarker Profiling Using NULISA in a cohort enriched with risk for Alzheimer's Disease and Related Dementias.

Rea Reyes R, Wilson R, Langhough R, Studer R, Jonaitis E, Oomens J medRxiv. 2024; .

PMID: 39649596 PMC: 11623751. DOI: 10.1101/2024.11.28.24318162.

Neuropsychiatric Symptoms Associated With Frontotemporal Atrophy in Older Adults Without Dementia.

Liampas I, Siokas V, Stamati P, Kyriakoulopoulou P, Tsouris Z, Zoupa E Int J Geriatr Psychiatry. 2024; 39(12):e70008.

PMID: 39617744 PMC: 11609132. DOI: 10.1002/gps.70008.

Cerebral amyloid angiopathy impacts neurofibrillary tangle burden and cognition.

Godrich D, Pasteris J, Martin E, Rundek T, Schellenberg G, Foroud T Brain Commun. 2024; 6(6):fcae369.

PMID: 39584156 PMC: 11581998. DOI: 10.1093/braincomms/fcae369.

References

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

Darby D, Maruff P, Collie A, McStephen M . Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology. 2002; 59(7):1042-6. DOI: 10.1212/wnl.59.7.1042. View

Theisen M, Rapport L, Axelrod B, Brines D . Effects of practice in repeated administrations of the Wechsler Memory Scale Revised in normal adults. Assessment. 1998; 5(1):85-92. DOI: 10.1177/107319119800500110. View

Benedict R, Zgaljardic D . Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol. 1998; 20(3):339-52. DOI: 10.1076/jcen.20.3.339.822. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

Burton C, Strauss E, Hultsch D, Moll A, Hunter M . Intraindividual variability as a marker of neurological dysfunction: a comparison of Alzheimer's disease and Parkinson's disease. J Clin Exp Neuropsychol. 2006; 28(1):67-83. DOI: 10.1080/13803390490918318. View

Beekly D, Ramos E, Lee W, Deitrich W, Jacka M, Wu J . The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord. 2007; 21(3):249-58. DOI: 10.1097/WAD.0b013e318142774e. View

Howieson D, Carlson N, Moore M, Wasserman D, Abendroth C, Payne-Murphy J . Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc. 2008; 14(2):192-8. DOI: 10.1017/S1355617708080375. View

Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford N, Chui H . The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009; 23(2):91-101. PMC: 2743984. DOI: 10.1097/WAD.0b013e318191c7dd. View

10.

Fong T, Fearing M, Jones R, Shi P, Marcantonio E, Rudolph J . Telephone interview for cognitive status: Creating a crosswalk with the Mini-Mental State Examination. Alzheimers Dement. 2009; 5(6):492-7. PMC: 2783323. DOI: 10.1016/j.jalz.2009.02.007. View

11.

Dalrymple-Alford J, MacAskill M, Nakas C, Livingston L, Graham C, Crucian G . The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010; 75(19):1717-25. DOI: 10.1212/WNL.0b013e3181fc29c9. View

12.

Dodge H, Wang C, Chang C, Ganguli M . Terminal decline and practice effects in older adults without dementia: the MoVIES project. Neurology. 2011; 77(8):722-30. PMC: 3164394. DOI: 10.1212/WNL.0b013e31822b0068. View

13.

Gamaldo A, An Y, Allaire J, Kitner-Triolo M, Zonderman A . Variability in performance: identifying early signs of future cognitive impairment. Neuropsychology. 2012; 26(4):534-40. PMC: 3530416. DOI: 10.1037/a0028686. View

14.

Dong Y, Yean Lee W, Basri N, Collinson S, Merchant R, Venketasubramanian N . The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012; 24(11):1749-55. DOI: 10.1017/S1041610212001068. View

15.

Freitas S, Simoes M, Alves L, Vicente M, Santana I . Montreal Cognitive Assessment (MoCA): validation study for vascular dementia. J Int Neuropsychol Soc. 2012; 18(6):1031-40. DOI: 10.1017/S135561771200077X. View

16.

Ivanova I, Salmon D, Gollan T . The multilingual naming test in Alzheimer's disease: clues to the origin of naming impairments. J Int Neuropsychol Soc. 2013; 19(3):272-83. PMC: 4356120. DOI: 10.1017/S1355617712001282. View

17.

Cameron J, Worrall-Carter L, Page K, Stewart S, Ski C . Screening for mild cognitive impairment in patients with heart failure: Montreal cognitive assessment versus mini mental state exam. Eur J Cardiovasc Nurs. 2012; 12(3):252-60. DOI: 10.1177/1474515111435606. View

18.

Roalf D, Moberg P, Xie S, Wolk D, Moelter S, Arnold S . Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2012; 9(5):529-37. PMC: 4036230. DOI: 10.1016/j.jalz.2012.10.001. View

19.

Morris J, Ernesto C, Schafer K, Coats M, Leon S, Sano M . Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology. 1997; 48(6):1508-10. DOI: 10.1212/wnl.48.6.1508. View